Description
ISOSULFAN BLUE FOR CENTRAL IOWA
First action · last action
2013-06-24 · 2013-06-25
Transactions
2
First transaction's obligation
$2,472
Base + all options value (sum of deltas)
$11,000
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
SMALL BUSINESS SET ASIDE - TOTAL
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-06-24+$2,472= $2,472
- Mod P000012013-06-25+$8,528= $11,000
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-06-24 | +$2,472 | $2,472 | ISOSULFAN BLUE FOR CENTRAL IOWA |
| Mod P00001· FUNDING ONLY ACTION | 2013-06-25 | +$8,528 | $11,000 | ISOSULFAN BLUE FOR CENTRAL IOWA |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JQUEGW4VJT54)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA77016P1379 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $13,650 | FY2016 |
| VA77016P1135 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2016 |
| VA77016P1062 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2016 |
| VA77016P0843 | NATIONAL CMOP OFFICE (NCO) · 6505 · DRUGS AND BIOLOGICALS | $30,360 | FY2016 |
| VA77016P0801 | NATIONAL CMOP OFFICE (NCO) · 6505 · DRUGS AND BIOLOGICALS | $18,028 | FY2016 |
| VA77016P0653 | NATIONAL CMOP OFFICE (NCO) · 6505 · DRUGS AND BIOLOGICALS | $24,750 | FY2016 |
Other recipients under 6505 from 437-FARGO VA MEDICAL CENTER (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26316J0415 | SANOFI VACCINES US INC. | 437-FARGO VA MEDICAL CENTER | $42,503 | FY2016 |
| VA26316J0414 | SEQIRUS USA INC | 437-FARGO VA MEDICAL CENTER | $62,900 | FY2016 |
| VA26316J0399 | SEQIRUS USA INC | 437-FARGO VA MEDICAL CENTER | $52,207 | FY2016 |
| VA26316J0411 | SANOFI VACCINES US INC. | 437-FARGO VA MEDICAL CENTER | $141,675 | FY2016 |
| VA26316J0389 | CSL BEHRING L.L.C. | 437-FARGO VA MEDICAL CENTER | $14,281 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26313P1597_3600_-NONE-_-NONE- · retrieved 2026-09-26.